Title:
COMBINED PHARMACEUTICAL COMPOSITION OF ANTI-PD-L1 ANTIBODY AND C-MET KINASE INHIBITOR FOR TREATING LUNG CANCER
Document Type and Number:
WIPO Patent Application WO/2022/111618
Kind Code:
A1
Abstract:
The present invention relates to a combined pharmaceutical composition of an anti-PD-L1 antibody and a c-Met kinase inhibitor for treating lung cancer, and specifically to a combined pharmaceutical composition of an anti-PD-L1 antibody and N-(4-((7-((1-(cyclopentylamino)cyclopropyl)methoxy)-6-methoxyquinolin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1, 1-dimethylamide for treating lung cancer, and a use of the combined pharmaceutical composition in the treatment of lung cancer.
Inventors:
ZHANG XIQUAN (CN)
WANG XUNQIANG (CN)
YU DING (CN)
LIU TAO (CN)
ZHAN XIAOLE (CN)
WU NAIYING (CN)
WANG XUNQIANG (CN)
YU DING (CN)
LIU TAO (CN)
ZHAN XIAOLE (CN)
WU NAIYING (CN)
Application Number:
PCT/CN2021/133386
Publication Date:
June 02, 2022
Filing Date:
November 26, 2021
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
A61P35/00; A61K31/4709; A61K39/395; A61P11/00; C07K1/06
Domestic Patent References:
| WO2019173523A1 | 2019-09-12 |
Foreign References:
| CN111617243A | 2020-09-04 | |||
| CN111973739A | 2020-11-24 | |||
| CN111936467A | 2020-11-13 | |||
| CN107750166A | 2018-03-02 | |||
| CN108883180A | 2018-11-23 | |||
| AU2012200204A1 | 2012-02-09 |
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF:
Previous Patent: MODEL TRAINING METHOD AND APPARATUS
Next Patent: IMAGE PROCESSING METHOD AND RELATED APPARATUS
Next Patent: IMAGE PROCESSING METHOD AND RELATED APPARATUS